| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.12.25 | KDA Group Inc: KDA obtains conditional TSX-V OK for GTK share purchase | 1 | Stockwatch | ||
| 22.12.25 | Kda Group Announces A Collaboration To Integrate New Clinical Alerts Into The Medherize Platform To Support The Adoption Of Next-generation Sequencing For Breast Cancer Patients | 1 | CNW | ||
| 03.12.25 | Kda Group Announces Partnership Agreement With Chu De Québec-université Laval For The Deployment Of Medherize | 1 | CNW | ||
| KDA GROUP Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | Kda Group Deploys Medherize Across Community Pharmacies: A Major Step Forward In The Management Of Oral Anticancer Therapies | 1 | CNW | ||
| 26.11.25 | KDA Group To Acquire 20% Stake In Subsidiary GTK From ERxpert | 1 | RTTNews | ||
| 26.11.25 | KDA Group Inc: KDA Group to acquire 20% of ERxpert subsidiary | 2 | Stockwatch | ||
| 25.11.25 | Kda Group Announces Agreement To Acquire Minority Interest In Its Subsidiary Groupe Technologique Kda Inc. | 1 | CNW | ||
| 18.11.25 | KDA Group Inc: KDA Group opens U.S. subsidiary for Medherize launch | 1 | Stockwatch | ||
| 17.11.25 | Kda Group Opens A U.s. Subsidiary And Accelerates The Growth Of Its Medherize Solution | 1 | CNW |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,470 | +0,64 % | Gewinnwarnung von FMC, Oerlikon mit Sonderdividende und Takkt muss Dividende streichen - BÖRSE TO GO | Fresenius Medical Care überraschte am Morgen mit einer Gewinnwarnung. Trotz des starken Gewinnsprungs im Vorjahr sieht man schwarz für 2026. Oerlikon kündigte nach dem Barmag Verkauf eine Sonderdividende... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,120 | -0,59 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| UNITEDHEALTH | 248,15 | -0,04 % | Dividend Roundup: Home Depot, UnitedHealth, Cigna, Nvidia, and more | ||
| HIMS & HERS HEALTH | 12,285 | +0,08 % | Marge kollabiert: Hims stürzt nach Prognose ab - Novo Nordisk bleibt der Brandbeschleuniger | © Foto: Thomas Fuller - SOPA Images via ZUMA Press WireTrotz starker Q4-Zahlen reißt der neue Ausblick ein Loch in die Story. Hohe Ausgaben, ein schwaches erstes Quartal und der Novo-Konflikt setzen... ► Artikel lesen | |
| BICO GROUP | 1,696 | -0,41 % | BICO Group AB: Publication of BICO Group AB: Year-end report 2025 | Strong Lab Automation growth and higher cash balance
Q4 2025 SummaryLab Automation delivered 15 percent organic sales growth YoY. This was primarily driven by accelerated project completions and additional... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | -6,59 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| UNIDOC HEALTH | 0,066 | 0,00 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| VERU | 2,560 | -4,48 % | Veru Inc.: Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress | -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast... ► Artikel lesen | |
| CLARIANE | 4,054 | +0,05 % | Clariane: Full-year 2025 results | Solid 2025 resultsDebt reduction trajectory confirmedGrowth objectives for 2025-2028 All tables are available in the PDF. Successful plan to strengthen the financial position and confirmed debt... ► Artikel lesen | |
| VIROMED MEDICAL | 6,300 | -1,56 % | EQS-DD: Viromed Medical AG: Uwe Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.02.2026 / 17:05... ► Artikel lesen | |
| SENSEONICS | 6,900 | -1,43 % | Senseonics Q4 2025 Earnings Preview | ||
| BONESUPPORT | 19,000 | -0,37 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes year-end report 2025 | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the year-end report for the fourth quarter and full year 2025.
"Strong growth... ► Artikel lesen | |
| GLOBAL HEMP GROUP | 0,014 | -100,00 % | Global Hemp Group Inc.: Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing | Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") announces that it has applied to the British... ► Artikel lesen | |
| BEYOND AIR | 0,961 | +0,33 % | Beyond Air Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update | Increased revenue by 105% year-over-year (YoY) to $2.2 million in fiscal Q3 Maintain fiscal year 2026 revenue guidance of $8-10 million $22.3 million pro forma cash, cash equivalents, restricted... ► Artikel lesen | |
| M3 INC | 9,300 | +1,09 % | M3, Inc. Nine Months Income Climbs | TOKYO (dpa-AFX) - M3, Inc. (4YC.F) released a profit for its nine months that Increased, from the same period last yearThe company's earnings came in at JPY41.650 billion, or JPY61.39 per share.... ► Artikel lesen |